Latest Breaking News On - New therapies - Page 2 : comparemela.com

New Therapies: Bridge Knowledge, Speed and Quality

How quickly and effectively can you deliver breakthrough, high-quality new therapies to market?

New therapiesBridge knowledge

Vaccitech Renames as Barinthus Biotherapeutics to Highlight

New Corporate Brand to be Unveiled at AASLD Liver Meeting® 2023 with Interim Data OXFORD, United Kingdom, Nov. 06, 2023 (GLOBE NEWSWIRE) Barinthus.

Israel generalUnited statesUnited kingdomChristopherm calabreseKevin gardnerKing arthurBarinthus biotherapeuticBarinthus biotherapeuticsJonothan blackbournAstrazeneca oxfordAudra friisArbutus biopharma corporationUniversity of oxfordExchange commissionSam brown incNew corporate brand

Vaccitech Renames as Barinthus Biotherapeutics to Highlight Strategic Evolution into a T Cell Immunotherapy Company Targeting Chronic Infectious Diseases, Autoimmunity, and Cancer

Vaccitech Renames as Barinthus Biotherapeutics to Highlight Strategic Evolution into a T Cell Immunotherapy Company Targeting Chronic Infectious Diseases, Autoimmunity, and Cancer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United kingdomIsrael generalUnited statesAstrazeneca oxfordKevin gardnerJonothan blackbournKing arthurBarinthus biotherapeuticsAudra friisChristopherm calabreseBarinthus biotherapeuticExchange commissionUniversity of oxfordArbutus biopharma corporationSam brown incHighlight strategic evolution

NKGen Biotech Announces Poster Presentation at the 16th Annual Clinical Trials on Alzheimer s disease Conference

SANTA ANA - NKGen Biotech Inc. , a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell.

United statesCesar alejandro amescuaBlanca isaura acosta galloClemente humberto zuniga gilLucia huiJuan mataThank leeDenise chuaSean hongKatia betitoRufino menchaca diazPauly changExchange commissionNkgen biotech incClinical trialsDisease annual meeting

Arbutus Announces Multiple Abstracts Accepted for Presentation at AASLD - The Liver Meeting® 2023

Imdusiran data will be highlighted in late breaking presentation WARMINSTER, Pa., Oct. 11, 2023 Arbutus Biopharma Corporation , a clinical-stage biopharmaceutical company leveraging its.

United statesMark andersonGavin clohertySam galhenageMarie louise vachonMagdy elkhashabKrasimir antonovArpita mondalChao wei hsuVarun sharmaCalvin chanScott davisonKaren simsRobert baileyStuartk robertsChristine espiritu